Documents

Ideas Discussions Technicals Forecast Seasonals

Cellectar Biosciences, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from Cellectar Biosciences, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Data partner

Description

Reported date

Form

2025

Q2 2025

Aug 14, 2025

Transcript

Earnings release8-K

Quarterly report10-Q

Q1 2025

May 13, 2025

Transcript

Earnings release8-K

Quarterly report10-Q

Oppenheimer 35th Annual Healthcare Life Sciences Conference (Virtual) 2025

Feb 12, 2025

Transcript

2024

Q4 2024

Mar 13, 2025

Transcript

Earnings release8-K

Annual report10-K

Q3 2024

Nov 18, 2024

Earnings release8-K

Quarterly report10-Q

Q2 2024

Aug 13, 2024

Quarterly report10-Q

Earnings release8-K

Study Update

Jul 24, 2024

Press release

Q1 2024

May 14, 2024

Quarterly report10-Q

Earnings release8-K

Study Update

Jan 08, 2024

Press release

2023

Q4 2023

Mar 27, 2024

Earnings release8-K

Annual report10-K

Q3 2023

Nov 02, 2023

Quarterly report10-Q

Earnings release8-K

Q2 2023

Aug 14, 2023

Quarterly report10-Q

Earnings release8-K

Q1 2023

May 04, 2023

Quarterly report10-Q

Earnings release8-K

2022

Q4 2022

Mar 09, 2023

Annual report10-K

2021

Q4 2021

Mar 21, 2022

Annual report10-K

2020

Q4 2020

Mar 02, 2021

Annual report10-K

2019

Q4 2019

Mar 09, 2020

Annual report10-K

2018

Q4 2018

Feb 26, 2019

Annual report10-K

2017

Q4 2017

Mar 21, 2018

Annual report10-K

2016

Q4 2016

Mar 15, 2017

Annual report10-K

2015

Q4 2015

Mar 11, 2016

Annual report10-K